Dr. Bourgoin is a regular researcher at the Research Center of Quebec – Laval University and Professor in the Department of Microbiology-Infectiology and Immunology of the Faculty of Medicine at Laval University. His work focuses on lipid mediators of inflammation in systemic autoimmune diseases and dysfunction of innate immunity cells.
Dr. Bourgoin has published more than 100 articles in scientific journals (Google Scholar h-index of 39). His work has been the subject of several editorial reviews of scientific journals in 2108 (Molecular Pharmacology) and in 2011 (Journal of Leukocyte Biology). Dr. Bourgoin contributes to the influence of the CHU Research Centre and Laval University by organizing international symposia on neutrophils in immunity (2012, 2014, 2016, 2018).
Understanding early atherosclerosis in rheumatic autoimmune diseases:
Accelerated atherosclerosis, associated with systemic autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis, significantly increases the risk of cardiovascular events. The lipid mediators of inflammation play an amplifying role in the development of atherosclerosis, promoting the recruitment of immune system cells and the thickening of the vessel wall. Strategies to reduce cardiovascular risks associated with lupus erythematosus and rheumatoid arthritis remain to be clarified.
A new target to treat leukemia:
Myeloid leukemias are blood cancers whose origin is an anarchic production of white blood cells, from the bone marrow. These cells are usually immature, and unable to fight infections. Their presence also tends to disrupt the production of red blood cells, and cause a decline in the production of platelets. Genetic and epigenetic modifications alter the expression or function of proteins that act as positive or negative regulators of proliferation. These molecular switches abundant in leukemic myeloid cells act as positive regulators of proliferation, while inhibiting their differentiation into functional white blood cells.
2705, boulevard Laurier
T1-58
Québec, Québec
Canada G1V 4G2
Latest news
- Azoudj, KenzaMaster studentCHUL+1 418-525-4444, extension 42296kenza.azoudj.1@ulaval.cakenza.azoudj@crchudequebec.ulaval.ca
2705, boulevard Laurier
T1-49
Québec, QC
Canada G1V 4G2 - Bouabane, MarouaneMaster studentCHUL+1 418-525-4444, extension 42296marouane.bouabane.1@ulaval.camarouane.bouabane@crchudequebec.ulaval.ca
2705, boulevard Laurier
T1-49
Québec, QC
Canada G1V 4G2 - Gignac, JulesMaster studentCHUL+1 418-525-4444, extension 42296jules.gignac.1@ulaval.cajules.gignac@crchudequebec.ulaval.ca
2705, boulevard Laurier
T1-49
Québec, QC
Canada G1V 4G2 - Mortazavi, HelyaEmployeeCHUL+1 418-525-4444, extension 42296helya.mortazavi@crchudequebec.ulaval.ca
2705, boulevard Laurier
T1-48
Québec, QC
Canada G1V 4G2
Metabolic regulation of neutrophil functions in homeostasis and diseases
Journal ArticleJ Leukoc Biol, 116 (3), 2024.
Functional Role of AGAP2/PIKE-A in Fcγ Receptor-Mediated Phagocytosis
Journal ArticleCells, 12 (1), 2022.
Phospholipase A1 Member A Deficiency Alleviates Mannan-Induced Psoriatic Arthritis in Mice Model
Journal ArticleInt J Mol Sci, 23 (15), 2022.
Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus
Journal ArticleLupus Sci Med, 9 (1), 2022.
Corrigendum to "Arf6 regulates energy metabolism in neutrophils" [Free Radic Biol Med. 172 (2021) 550-561]
Journal ArticleFree Radic Biol Med, 179 , 2022.
Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules
Journal ArticleBlood, 138 (25), 2021.
Phosphatidylserine-specific phospholipase A1: A friend or the devil in disguise
Journal ArticleProg Lipid Res, 83 , 2021.
Arf6 regulates energy metabolism in neutrophils
Journal ArticleFree Radic Biol Med, 172 , 2021.
Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
Journal ArticleInt J Mol Sci, 22 (23), 2021.
Interplay between LPA2 and LPA3 in LPA-mediated phosphatidylserine cell surface exposure and extracellular vesicles release by erythrocytes
Journal ArticleBiochem Pharmacol, 192 , 2021.
Active projects
- Metabolic mechanisms of pro-resolutive neutrophils in chronic inflammatory diseases, from 2024-04-01 to 2029-03-31
- Role of phosphatidylserine-specific phospholipase A1 (PLA1A) in the pathogenesis of rheumatic diseases, from 2023-01-01 to 2025-12-31
Recently finished projects
- Role of autotaxin bound to platelet-derived microparticles to development of vascular damage in arthritis., from 2015-07-01 to 2023-03-31